| IDU | idoxuridine; injection or intravenous drug user; iododeoxyuridine |
|---|---|
| IND | indomethacin; industrial medicine; investigational new drug |
| ISD | immunosuppressive drug; Information Services Division; inhibited sexual desire; interstimulus distan... |
| KDA | known drug allergies |
| LA | lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left... |
| drug idiosyncrasy |
An unusual response to a drug. It can manifest as an accelerated, toxic, or inappropriate response to the usual therapeutic dose of a drug. SYN: idiosyncrasy of effect.
Ãâó:
|
|---|---|
| drug monograph |
A publication that specifies for a drug (or class of related drugs) the kinds and amounts of ingredients it may contain, the conditions and limitations for which it may be offered, directions for use, warnings, and other informati
Ãâó:
|
| drug of abuse |
Any agent that impairs behavior, health, social interactions, or thought and is difficult not to use compulsively. Many of these agents, including ecstasy, lysergic acid (LSD), methamphetamines, the opiates, and phencyclidine, are
Ãâó:
|
| drug overdose |
The clinical consequence of any excess dose of a drug (e.g., of a self-administered, potentially lethal dose of a drug of abuse, an antidepressant, a non-narcotic pain reliever, or other medication). Drug overdose may be unintentio
Ãâó:
|
| drug product problem reporting program |
A program managed by the U.S. Pharmacopeial Convention, Inc., that informs the product manufacturer, the labeler, and the Food and Drug Administration (FDA) of potential health hazards and defective drug pr
Ãâó:
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|